Menu Back toSession-0804-How-is-DAA-Era-Changing-the-Chronic-HCV-Management-Efficient-Clinical-Development

The 7th DIA China Annual Meeting


Session 0804 How is DAA Era Changing the Chronic HCV Management - Efficient Clinical Development

Session Chair(s)

Jessica  Liu, MD

Jessica Liu, MD

  • VP
  • TIGERMED CO.,LTD., China

Hepatitis C Status and Umet Needs WEI-Shanghai 20150526-new

Speaker(s)

Lai  Wei

Hepatitis C Status and Umet Needs WEI-Shanghai 20150526-new

Lai Wei

  • PKU People's Hospital, China
Jinzi  Wu

Jinzi Wu

  • Ascletis BioScience Co., Ltd., China
Tao  Wang, MD, PhD

Tao Wang, MD, PhD

  • Director of Chemical Medicine Evaluation office II
  • China Food and Drug Administration (CFDA), China

Contact us

For exhibition, advertising and hosting inquiry, please contact:
Jean XU: jxu@kellencompany.com, or Sofie Peeters: speeters@kellencompany.com
Tel: +86 10 5923 1096

For general inquiry, please contact DIA China office:
dia@diachina.org
Tel: +86 10 5704 2650